Here’s Why Big Pharma and Private Equity Invest in Drug Discovery Companies

Big Pharma and Private Equity firms invest in drug discovery companies and biotech startups due to the high cost of R&D and better ROI. By Michael Megarit. A recent Deloitte report reveals that the R&D returns of the 15 leading US biopharma companies are just 2.5% in 2020, down from a [...]

Here’s Why Big Pharma and Private Equity Invest in Drug Discovery Companies2021-11-15T21:15:55+00:00

Here’s How Investment Banks are Dealmaking in the Indian Tech Sector

American investment banks are brokering billions of dollars worth of deals in the Indian tech sector. By Michael Megarit India is a battleground for American tech companies looking for growth opportunities. With more than 560 million active Internet users and an equal number expected to connect over the course of the [...]

Here’s How Investment Banks are Dealmaking in the Indian Tech Sector2021-11-15T21:18:21+00:00

Why are American Corporations Buying Indian Tech Companies?

Since 2020, US tech giants have invested more than $20 billion in Indian tech companies in an effort to enter the world’s fastest developing tech market. By Michael Megarit Why are American Corporations Buying Indian Tech Companies? 2020 was a landmark year for the Indian tech industry: January 2020: Amazon pledged [...]

Why are American Corporations Buying Indian Tech Companies?2021-11-16T11:41:11+00:00

3 Reasons Why Now Is the Best Time For Tech Founders To Sell Or Go Public

By Michael Megarit There has never been a better time for the founders of tech companies to sell or go public. A lucrative exit is the dream of many investors. Founders, on the other hand, aspire to raise capital, achieve unicorn status and go public through blockbuster IPOs. The good news [...]

3 Reasons Why Now Is the Best Time For Tech Founders To Sell Or Go Public2021-11-16T11:47:30+00:00
Go to Top